Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity

Biochemical Pharmacology

Volumn 85, Issue 1, 2013, Pages 124-134

  Sishi, Balindiwe J N ^a   Loos, Benjamin ^a   Van Rooyen, Jacques ^b   Engelbrecht, Anna Mart ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Autophagy; Cardiotoxicity; Doxorubicin; GFP LC3; Mitochondria; Rapamycin

Indexed keywords

BAFILOMYCIN A1; CASPASE 3; DOXORUBICIN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; AUTOPHAGY; BIOCHEMISTRY; CARDIOTOXICITY; CELL VIABILITY; CONTROLLED STUDY; EXCISION; HEART CELL CULTURE; HEART MUSCLE CELL; HISTOPATHOLOGY; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; AUTOPHAGY; CASPASE 3; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG ANTAGONISM; FEMALE; MACROLIDES; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MYOBLASTS, CARDIAC; MYOCARDIUM; NEOPLASM TRANSPLANTATION; RATS; REACTIVE OXYGEN SPECIES; SIROLIMUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84871718306     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.10.005     Document Type: Article

References (55)

1. E.P. Cortez, G. Lutman, J. Wanka, J. Wang, J. Pickren, and J.J. Wallace Adriamycin (NSC-123127) cardiotoxicity: a clinicopathologic correlation (Part 3) Cancer Chemother Rep 6 1975 215 225
2. E.A. Lefrak, J. Pitha, S. Rosenheim, B.M. O'Bryan, M.A. Burgess, and J.A. Gottlieb Adriamycin (NSC 123127) cardiomyopathy Cancer Chemother Rep 6 1975 203 208
3. R.A. Minow, R.S. Benjamin, and J.A. Gottllieb Adriamycin (NSC-123127) cardiomyopathy-an overview with determination of risk factors Cancer Chemother Rep 6 1975 185 201
4. R.A. Minow, R.S. Benjamin, E.T. Lee, and J.A. Gottllieb Adriamycin cardiomyopathy-risk factors Cancer 39 1977 1397 1402
5. T. Petit Anthracycline-induced cardiotoxicity Bull Cancer 91 2004 159 165
6. P.K. Singal, C.M.R. Derally, and L.E. Weinberg Subcellular effects of Adriamycin in the heart: a concise review J Mol Cell Cardiol 19 1987 817 828
7. P.K. Singal, N. Siveski-Illiskovic, M. Hill, T.P. Thomas, and T. Li Combination therapy with probucol prevents Adriamycin-induced cardiomyopathy J Mol Cell Cardiol 27 1995 1055 1063
8. Y.J. Kang, Y. Chen, and P.N. Epstein Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice J Biol Chem 271 1996 12610 12616
9. D. Kumar, I.A. Kirshenbaum, T. Li, I. Danelisen, and P.K. Singal Apoptosis in adriamycin cardiomyopathy and its modulation by Probucol Antioxid Redox Signal 3 2001 135 145
10. X. Sun, Z. Zhou, and Y.P. Kang Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart Cancer Res 61 2001 3382 3387
11. E.J. Ladas, J.S. Jacobson, D.D. Kennedy, K. Teel, A. Fleischauer, and K.M. Kelly Antioxidants and cancer therapy: a systematic review J Clin Oncol 22 2004 517 528
12. R.A. Gottlieb, K.D. Finley, and R.M. Mentzer Jr. Cardioprotection requires taking out the trash Basic Res Cardiol 104 2009 169 180
13. L.A. Passmore, and D. Barford Getting into position: the catalytic mechanisms of protein ubiquitylation Biochem J 379 2004 513 525
14. M.S. Willis, W.H.D. Townley-Tilson, E.Y. Kang, J.W. Homeister, and C. Patterson Sent to destroy: the ubiquitin proteasome system regulates cell signalling and protein quality control in cardiovascular development and disease Circ Res 106 2010 463 478
15. Q. Zheng, J. Li, and X. Wang Interplay between the ubiquitin proteasome system and autophagy in proteinopathies Int J Physiol Pathophysiol Pharmacol 1 2009 127 142
16. A. Nakai, O. Yamaguchi, T. Takeda, Y. Higuchi, S. Hikoso, and M. Taniike The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress Nat Med 13 2007 619 624
17. B. Loos, A. Lochner, and A.-M. Engelbrecht Autophagy in heart disease: a strong hypothesis for an untouched metabolic reserve Med Hypotheses 77 2011 52 57
18. Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, and T. Asano Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy Circ Res 100 2007 914 922
19. L. Yan, D.E. Vatner, S.J. Kim, H. Ge, M. Masurekar, and W.H. Massaover Autophagy in chronically ischemic myocardium Proc Natl Acad Sci USA 102 2005 13807 13812
20. B. Levine, and J. Yuan Autophagy in cell death: an innocent convict? J Clin Invest 115 2005 2679 2688
21. B.A. Rothermel, and J.A. Hill Autophagy in load-induced heart disease Circ Res 103 2008 1363 1369
22. Z.N. Demidenko, and M.V. Blagosklonny Growth stimulation leads to cellular senescence when the cell cycle is blocked Cell Cycle 7 2008 3355 3361
23. R. Namba, L.J.T. Young, C.A. Abbey, L. Kim, P. Damonte, and A.D. Borowsky Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ Clin Cancer Res 12 2006 2613 2621
24. Q. Wu, K. Kuguchi, T. Kawanoto, T. Ajiki, J. Traag, and S. Carbajal Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model Cancer Res 67 2007 3794 3800
25. J. Hausleiter, A. Kastrsti, J. Mehilli, M. Vogesser, D. Zohlnhöfer, and H. Schühlen Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis in patients with in-stent restenosis: the oral sirolimus to inhibit recurrent in-stent stenosis (OSIRIS) trial Circulation 110 2004 790 795
26. J.R. McMullen, M.C. Sherwood, O. Tarnavski, L. Zhang, A.L. Dorfman, and T. Shioi Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload Circulation 109 2004 3050 3055
27. T. Shioi, J.R. McMullen, O. Tarnavski, K. Converso, M.C. Sherwood, and W.J. Manning Rapamycin attenuates load-induced cardiac hypertrophy in mice Circulation 107 2003 1664 1670
28. L.A. Gomez, A.E. Alekseev, L.A. Aleksandrova, P.A. Brady, and A. Terzic Use of MTT assay in adult ventricular cardiomyocytes to assess viability. Effects of adenosine and potassium on cellular survival J Mol Cell Cardiol 29 1997 1255 1266
29. M.M. Bradford A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
30. A. Ewans, L. Luo, E. Berleth, J. Alderfer, R. Wollman, and B.B. Hafeez Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice Cancer Res 66 2006 5419 5426
31. W. Zhu, M.H. Soonpaa, H. Chen, W. Shen, R.M. Patne, and E.A. Liechty Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway Circulation 119 2009 99 106
32. C. Kang, and L. Avery To be or not to be, the level of autophagy is the question: dual roles of autophagy in the survival response to starvation Autophagy 4 2008 82 84
33. B. Loos, S. Genade, B. Ellis, A. Lochner, and A.-M. Engelbrecht At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury Exp Cell Res 317 2011 1437 1453
34. A. Eisenberg-Lerner, S. Bialik, H.U. Simon, and A. Kimchi Life and death partners: apoptosis, autophagy and cross-talk between them Cell Death Differ 16 2009 966 975
35. S. Kobayashi, P. Volden, D. Timm, K. Mao, X. Xu, and Q. Liang Transcription factor GATA4 inhibits doxorubicin-induced autophagy J Biol Chem 285 2010 793 804
36. O.J. Arola, A. Saraste, K. Pulkki, M. Kallajoi, M. Parvinen, and L.-M. Voipio-Pulkki Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis Cancer Res 60 2000 1789 1792
37. Y.J. Kang Molecular and cellular mechanisms of cardiotoxicity Environ Health Perspect 109 2001 27 34
38. K. Shan, M. Lincoff, and J.B. Young Anthracycline-induced cardiotoxicity Ann Intern Med 125 1996 47 58
39. J. Liu, H. Zheng, M. Tang, Y.-C. Ryu, and X. Wang A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome Am J Physiol Heart Circ Physiol 295 2008 H2541 H2550
40. K.S. Dimmer, and L. Scorrano (De)constructing mitochondria: what for? Physiology (Bathesda) 21 2006 233 241
41. D.J. Hausenloy, and L. Scorrano Targeting cell death Clin Pharmacol Ther 82 2007 370 373
42. S.-B. Ong, and D.J. Hausenloy Mitochondrial morphology and cardiovascular disease Cardiovasc Res 88 2010 16 29
43. K. Nicolay, J.J. Fok, W. Voorhout, J.A. Post, and B. de Kruijff Cytofluorescence detection of adriamycin-mitochondria interactions in isolated perfused rat heart Biochim Biophys Acta 887 1986 35 41
44. K.J.M. Schimmel, D.J. Richel, R.B.A. van den Brink, and H.-J. Guchelaar Cardiotoxicity of cytotoxic drugs Cancer Treat Res 30 2004 181 191
45. R.S. Vander Heide, and T.J. L'Ecuyer Molecular basis of anthracycline-induced cardiotoxicity Heart Metab 35 2007 1 4
46. H. Yuan, C.N. Perry, C. Huang, E. Ewasi-Kanai, R. Carreira, and C.C. Glembotski LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection Am J Physiol Heart Circ Physiol 296 2009 H470 H479
47. S.M. DeAtley, M.Y. Adsenov, M.V. Aksenova, B. Harris, R. Hadley, and P.C. Harper Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes Cancer Lett 136 1999 41 46
48. R.T. Dorr, K. Lagel, and S. McLean Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitro Eur J Cancer 32A 1996 S21 S25
49. Y.J. Kang, X. Sun, Y. Chen, and Z. Zhou Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts Chem Res Toxicol 15 2002 1 6
50. H.C. Yen, T.D. Oberley, S. Vichitbandha, Y.S. Ho, and D.K. St Clair The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice J Clin Invest 98 1996 1253 1260
51. R.D. Olson, and P.S. Mushlin Doxorubicin cardiotoxicity: analysis of prevailing hypotheses FASEB J 4 1990 3076 3086
52. X. Yi, R. Bekeredjian, N.J. DeFilippis, Z. Siddiquee, E. Fernandez, and R.V. Shohet Transcriptional analysis of doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol 290 2005 H1098 H1102
53. W. Zhu, W. Shou, R.M. Payne, R. Caldwell, and L.J. Field A mouse model for juvenile doxorubicin-induced cardiac dysfunction Pediatr Res 65 2008 488 494
54. A.M. Cuervo Autophagy and ageing: keeping that old broom working Trends Genet 24 2008 604 612
55. T. Vellai Autophagy genes and ageing Cell Death Differ 16 2009 94 102